Venture&Growth
Location
Dublin, Ireland
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Irish MedTech company focused on remote monitoring of heart failure patients.
FIRE1 is a connected medical device solutions company dedicated to improving outcomes for people suffering from chronic diseases. Its first product is a novel remote monitoring solution for heart failure patients. FIRE1 is led by an experienced medical devices team who are working closely with researchers, clinicians, patients and payors to help reduce the burden of heart failure.
More Fire1 news
Gilde Healthcare company FIRE1 raises $120 Million Financing to Revolutionize Heart Failure Care
Gilde Healthcare company FIRE1 raises $25 million to revolutionize heart failure home monitoring
Gilde Healthcare leads EUR 40 Million financing in Irish healthtech company FIRE1
Venture&Growth
Nyxoah
Belgian Healthtech company focused on the treatment of sleep apnea.
Venture&Growth
Amphista Therapeutics
Amphista Therapeutics is a UK-based company creating first-class therapeutics to selectively degrade and remove disease-causing proteins by harnessing the body’s natural processes. It’s next generation targeted protein degradation TPD-based medicines leverage novel mechanisms that make use of a wider range
Venture&Growth
Karius, Inc.
Karius is a U.S.-based diagnostic company that develops and commercializes an AI-based liquid biopsy test to diagnose serious infections in immunocompromised patients and other hospitalized patients. The company is commercial in the U.S. and provides strong potential for better care
